Key result
Fibroblast Hipk2 deletion worsens post-MI cardiac dysfunction, fibrosis, and inflammation in mice.
Why the study?
Does fibroblast-specific deletion of Hipk2 exacerbate myocardial fibrosis and inflammation post-MI in mice?
Does fibroblast-specific deletion of Hipk2 exacerbate myocardial fibrosis and inflammation post-MI in mice?
No takes yet. Share an insight, caveat, or question.
Fibroblast-specific Hipk2 deletion exacerbates myocardial fibrosis and inflammation post-MI, identifying Hipk2 as a potential therapeutic target for fibrosis-associated heart failure.
Jaiswal et al. (2025) studied Myocardial fibrosis and inflammation post-myocardial infarction. Fibroblast-specific Hipk2 deletion vs. Control mice was evaluated on Cardiac dysfunction and fibrosis post-MI. Fibroblast-specific Hipk2 deletion in mice exacerbated cardiac dysfunction, myocardial fibrosis, and inflammation 4 weeks post-myocardial infarction compared to controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: